Enovix (NASDAQ:ENVX) Shares Gap Up to $6.51

Enovix Co. (NASDAQ:ENVX - Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $6.51, but opened at $8.85. Enovix shares last traded at $8.23, with a volume of 5,848,066 shares traded.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ENVX. B. Riley lowered their target price on Enovix from $18.00 to $16.00 and set a "buy" rating on the stock in a report on Tuesday. Craig Hallum decreased their price target on Enovix from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Thursday. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $30.00 price objective on shares of Enovix in a research note on Thursday, April 25th. William Blair reissued an "outperform" rating on shares of Enovix in a research note on Thursday. Finally, JPMorgan Chase & Co. dropped their target price on Enovix from $18.00 to $12.00 and set an "overweight" rating for the company in a research report on Friday, April 26th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $25.29.

Read Our Latest Stock Analysis on Enovix

Enovix Trading Up 45.5 %

The company's fifty day moving average is $7.87 and its two-hundred day moving average is $10.01. The company has a quick ratio of 5.15, a current ratio of 5.30 and a debt-to-equity ratio of 0.65. The stock has a market cap of $1.61 billion, a price-to-earnings ratio of -5.90 and a beta of 1.70.


Enovix (NASDAQ:ENVX - Get Free Report) last posted its earnings results on Tuesday, February 20th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.34) by ($0.01). Enovix had a negative net margin of 2,800.51% and a negative return on equity of 77.74%. The business had revenue of $7.38 million during the quarter, compared to analysts' expectations of $3.37 million. On average, research analysts predict that Enovix Co. will post -1.13 EPS for the current fiscal year.

Insider Activity

In other Enovix news, COO Ajay Marathe sold 4,954 shares of the company's stock in a transaction on Sunday, April 14th. The shares were sold at an average price of $7.31, for a total value of $36,213.74. Following the completion of the transaction, the chief operating officer now owns 978,913 shares in the company, valued at $7,155,854.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 17.30% of the company's stock.

Hedge Funds Weigh In On Enovix

A number of hedge funds have recently modified their holdings of the business. SG Americas Securities LLC grew its holdings in shares of Enovix by 106.4% during the third quarter. SG Americas Securities LLC now owns 17,953 shares of the company's stock worth $225,000 after buying an additional 9,253 shares during the last quarter. U.S. Capital Wealth Advisors LLC acquired a new stake in Enovix during the 3rd quarter worth approximately $153,000. Commonwealth Equity Services LLC grew its stake in shares of Enovix by 37.2% in the 3rd quarter. Commonwealth Equity Services LLC now owns 57,245 shares of the company's stock valued at $718,000 after purchasing an additional 15,532 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in shares of Enovix by 10.1% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 32,833 shares of the company's stock valued at $412,000 after purchasing an additional 3,005 shares during the period. Finally, Raymond James & Associates raised its stake in shares of Enovix by 73.9% during the third quarter. Raymond James & Associates now owns 394,396 shares of the company's stock worth $4,950,000 after purchasing an additional 167,647 shares during the last quarter. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Should you invest $1,000 in Enovix right now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: